NASDAQ · Shell Companies · USD

Evolution Global Acquisition Corp (EVOX) Stock Analysis

Evolution Global Acquisition Corp (EVOX) is a Shell Companies stock listed on NASDAQ and quoted in US Dollar.

Last Updated: October 21, 2026

EVOX

$10.12

−$0.01 (−0.05%)

Oct 21, 2026 · Market close

Compare

Price History

Hover for the daily close. The dotted line marks the period open.

Compare EVOX with… →

EVOX Key Statistics

As of Oct 21, 2026

Trading

Open: $10.12
Previous Close: $10.13
52-Week Range: 9.86–10.15
Volume: 100.13K

Valuation

Market Cap: $323.84M

Financials (FY)

Shares Outstanding: 24.00M

Dividend and dates

Avg Volume: 73.67K

Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.

Key facts

Evolution Global Acquisition Corp (EVOX) has a market capitalization of $323.84M.

EVOX Stock Return by Calendar Year

Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.

Year	Return
2026 (partial year)	+2.53%
2025 (partial year)	−0.20%

As of October 21, 2026.

Analysis

Data-derived

Company Overview

Evolution Global Acquisition Corp (EVOX) is capitalised at $323.84M on the latest close. It is classified in the Shell Companies industry, within the Financial Services sector.

The 52-week range on file runs from $9.86 to $10.15. The most recent close on file for EVOX is $10.12, dated October 21, 2026. That is −$0.01 (−0.05%) against the previous close. The latest close sits 2.64% above that 52-week low.

Valuation Assessment

The stored price history starts on December 3, 2025, and the total return since then is +2.33%.

Growth & Income

No dividend is on file for EVOX.

So far in 2026 the total return is +2.53%.

Peer Comparison

Evolution Global Acquisition Corp (EVOX) operates in the Shell Companies industry. Here is how it compares to its closest peers by market capitalization:

Company	Ticker	Market Cap	P/E Ratio
Evolution Global Acquisition Corp	EVOX	$323.84M	—
Vylor Inc.	VYLR	$49.89B	106.8
Drugs Made In America Acquisition II Corp.	DMII	$649.10M	34.0
Churchill Capital Corp XI	CCXI	$621.61M	—

The Shell Companies industry average P/E ratio is 49.2x. Evolution Global Acquisition Corp has no P/E ratio because it is not currently profitable.

Every figure above is read from this page's own data on each daily rebuild. Informational only, not financial advice. As of October 21, 2026.

Related Shell Companies Stocks

VYLR

Vylor Inc.

$49.89B

DMII

Drugs Made In America Acquisition II Corp.

$649.10M

CCXI

Churchill Capital Corp XI

$621.61M

EVAC

EQV Ventures Acquisition Corp. II

$603.77M

BCSS

Bain Capital GSS Investment Corp.

$596.26M

CEPF

Cantor Equity Partners IV, Inc.

$587.79M

View all Shell Companies stocks →

Popular Financial Services Stocks

BRK-B

Berkshire Hathaway Inc.

$1.11T

JPM

JPMorgan Chase & Co.

$890.13B

Visa Inc.

$765.68B

Mastercard Incorporated

$545.42B

BAC

Bank of America Corporation

$358.24B

View all Financial Services stocks →

About Evolution Global Acquisition Corp

Evolution Global Acquisition Corp does not have significant operations. It focuses on entering into a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. The company was incorporated in 2025 and is based in Farmers Branch, Texas.

Visit website →